期刊文献+

前列腺癌骨转移疼痛患者综合护理干预的临床效果观察 被引量:3

The Observation of the Clinical Effect of Comprehensive Nursing on Bone Metastasis Pain in Patients with Prostate Cancer
下载PDF
导出
摘要 目的探究分析前列腺癌骨转移疼痛的临床护理干预方法及其效果。方法随机选取我院于2013年1月至2015年1月期间收治的64例前列腺癌骨转移疼痛患者为研究对象,并将其随机分为观察组和对照组,每组各32例,其中对照组患者给予常规护理干预,观察组患者在对照组的基础上增加针对性护理干预,对比观察两组患者疼痛症状的改善程度。结果观察组患者疼痛症状缓解率(93.75%)明显优于对照组(75.00%),两组比较具有显著性统计学意义(P<0.05)。结论前列腺癌转移疼痛患者接受综合护理干预的临床效果显著,能够有效改善患者的临床疼痛症状,对提高患者的生活质量质量具有积极的影响作用,值得临床推广应用。 Objective To study the effect of clinical nursing interventions on the patients with bone metastases pain from prostate cancer. Methods 64 patients were selected who suffered from bone metastases pain from prostate cancer in our hospital from January2013 to January 2015,and randomly divided into the observation group and the control group,with 32 patients in each group. The control group was given routine nursing intervention while besides routine approach,the observation group was also added targeted nursing intervention. Then the pain remission was compared in two groups. Results The pain remission rate( 93. 75%) in the observation group was statistically higher than that in the control group( 75. 00%,P 〈 0. 05). Conclusion The nursing intervention in patients with bone metastases pain from prostate cancer is effective,and it can relieve the pain and improve the quality of the patient’s life,worthy of clinical application.
作者 马鑫
出处 《锦州医科大学学报》 CAS 2017年第6期100-102,共3页 Journal of Jinzhou Medical University
关键词 前列腺癌 骨转移 疼痛 prostate cancer bone metastasis pain
  • 相关文献

参考文献3

二级参考文献28

  • 1杜敏,刘延超,王萍,曾宝珠.伊班膦酸钠并醋酸甲地孕酮对癌症骨转移癌患者疼痛及生活质量的影响[J].临床荟萃,2006,21(1):39-40. 被引量:3
  • 2谷铣之,殷蔚伯,余子豪,等.肿瘤放射治疗学[M].北京:中国协和医科大学出版社,2008:573.
  • 3Oster G, Lamerato L, Glass AG, et aL Natural history of skeletal related events in patients with breast, lung, or prostate cancer and metastases to bone:a 15-year study in two large US health systems. Support Care Cancer 2013; 21(12): 3279-3286.
  • 4Carlin BI, Andriole GL. The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma. Cancer 2000; 88 (12 Suppl): 2989-2994.
  • 5Rosen LS, Gordon D, Kaminski M, et al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double blind, comparative trial. Cancer J 2001 ; 7(5): 377-387.
  • 6Buga S, Sarria JE. The management of pain in metastatic bone disease. Cancer Control 2012; 19(2): 154-166.
  • 7Hamdy NA, Papapoulos SE. The palliative management of skeletal metastases in prostate cancer: Use of boneseeking radionuclides and bisphosphonates. Semin NuelMed2001; 31(1): 62-68.
  • 8Boissier S, Ferreras M, Peyruchaud O, et M. Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. Cancer Res 2000; 60(11): 2949-2954.
  • 9Jemal A, Bray F, Center M M, et al.Global cancer statistics[J]. CACancerJClin, 2011, 61 (4): 69, 90.
  • 10Ferlay J, Shin I-I R, Bray F D, et al.Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J].Int J Cancer, 2010, 127 (4) : 2893-2917.

共引文献18

同被引文献39

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部